Tag

SSRI Archives - Carey Danis & Lowe

New Study: Celexa & Zoloft Disrupt Unborn Baby Bone Growth

By | Pharmaceutical litigation, Uncategorized, Zoloft

topamax_birth_defects_topamax_lawsuit_settlementsCelexa and Zoloft, two drugs used to treat depression, are linked to many types of birth defects. And according to a recently published study, these two antidepressants are now linked to poor bone development.

The study, Citalopram and sertraline exposure compromises embryonic bone development, appeared in Molecular Psychiatry in September 2015.

The researchers looked at bone development in zebrafish embryos and human adult stem cells.

In both cases, they discovered that exposure to either Celexa (citalopram) or Zoloft (sertraline) resulted in inhibited bone growth.

In concluding their findings, the researchers emphasized that, “[t]hese results highlight the need to further investigate the risks of SSRI use during pregnancy in exposing unborn babies to potential skeletal abnormalities.”

WE CAN HELP YOU

Do you have questions about use of antidepressants like Celexa and Zoloft during pregnancy?

If so, contact the law offices of Carey Danis & Lowe. Our team includes experienced trial attorneys and medical professionals, who are both available to answer your questions and discuss your concerns.

If you used a selective serotonin reuptake inhibitor (SSRI) antidepressant, such as Celexa or Zoloft, during your pregnancy, and your child was born with birth defects, we encourage you to contact one of our SSRI birth defect lawyers today.

We offer free case evaluations, and can help you decide whether filing a Celexa or Zoloft birth defect lawsuit is right for you and your family.

Contact Carey Danis & Lowe today.

You can reach us by phone at 800.721.2519, or by completing a confidential personal injury claim form.

 

 

New Study Links Prozac & Paxil with Birth Defects

By | Paxil, Pharmaceutical litigation, Prozac, Uncategorized

ssri_birth_defectsA study published in the British Medical Journal links certain antidepressants with birth defects when used by pregnant women. The National Center on Birth Defects and Developmental Disabilities in Atlanta led the study.

Researchers looked at selective serotonin reuptake inhibitors, a class of antidepressants often referred to as SSRIs. The SSRIs included in the study were Paxil, Prozac, Celexa, Lexapro, and Zoloft.

The researchers recorded an increase in birth defects in children whose mothers used Prozac or Paxil early in their pregnancy. They reviewed 28,000 pregnancies between 1997 and 2009.

When women used Paxil one month before or during their first trimester, the risk of birth defects increased. For anencephaly, or a deformation of the skull, the risk rose from 2 per 10,000 to 7 per 10,000. For heart defects, the risk rose from 10 per 10,000 to 24 per 10,000.

In their study, the researchers emphasized that the Prozac and Paxil birth defects risk is small, but their findings do show a link. In light of this link, they called for further studies into the use of SSRI antidepressants in pregnant women.

It is highly recommended to speak with an obstetrician and mental health professional in order to make an informed decision about using SSRI antidepressants during pregnancy.

You are not alone.

At Carey Danis & Lowe, we understand the pain and suffering caused by birth defects. That’s why our team of experienced attorneys works tirelessly to recover losses for families impacted by Prozac birth defects or Paxil birth defects.

Interested in exploring your legal options?

Contact Carey Danis & Lowe today. We offer free case evaluations, during which we discuss your case, your compensation eligibility, and whether filing a Prozac or Paxil birth defects lawsuit is right for you.

You can reach our St. Louis law firm by phone at 800.721.2519, or by completing a confidential personal injury claim form.

We look forward to hearing from you, and offering you any assistance that we can.

Antidepressants & Pregnancy: Teen Files Prozac Birth Defects Lawsuit

By | Pharmaceutical litigation, Prozac, Uncategorized

SSRI Antidepressant Prozac Birth Defects LawsuitHaving suffered from Prozac birth defects, a Scottish teen has filed a lawsuit targeting Prozac maker, Eli Lilly. According to an article about the teen that was published by the Scottish news service, The Daily Record, the teen’s mother had used Prozac during her pregnancy.

The family believes that Prozac exposure in the womb caused the boy’s birth defects, which include a cleft lip and spina bifida.

The Prozac birth defects lawsuit has been filed in a court in Florida.

The combination of antidepressants and pregnancy being the cause of birth defects is a firm one. Unfortunately, many children have suffered tremendously from exposure to selective serotonin re-uptake inhibitor (SSRI) antidepressants, a category of antidepressant that includes Prozac, in the womb.

The U.S. Food and Drug Administration (FDA) has recognized an association between Prozac and birth defects, and thus, has recommended that the use of Prozac during pregnancy should only occur when benefits outweigh risks.

However, for the mother of the Scottish teen, such an analysis of benefits and risks was never undertaken, since, at the time she was using Prozac in the ’90s, there was still little understanding of how the antidepressant affected children in the womb.

Legal Assistance

Carey Danis & Lowe is a St. Louis law firm that represents families whose lives have been impacted by the use of SSRI antidepressants during pregnancy.

If your child suffered from birth defects after being exposed to an SSRI antidepressant, such as Prozac, in the womb, we encourage you and your family to explore legal options and compensation eligibility today.

Our law firm offers free, no-obligation case evaluations.

Contact Carey Danis & Lowe by phone at 800.721.2519, or by completing a confidential personal injury claim form. We look forward to offering you and your family any assistance that we can.

UCLA SSRI Study Examines Pregnancy & Drugs

By | Lexapro, Paxil, Pharmaceutical litigation, Prozac, Uncategorized, Zoloft

ssri_birth_defectsA UCLA study published in December 2014 examined the use of selective serotonin reuptake inhibitors, or SSRIs, during pregnancy. The researchers used lab mice to observe the effects of SSRI exposure in the womb, and how it impacts adult mice.

They observed that adult mice exposed to the SSRI, Lexapro, experienced a permanent change in serotonin transmission, whereas those adult mice exposed to Prozac in the womb, showed no signs of this permanent change.

The UCLA study examined a new side of SSRIs and pregnancy, one documenting the longterm implications of SSRI exposure in the womb, rather than the immediate.

The immediate implications of SSRI exposure in the womb, to a certain degree, are already known. Children have been born with life-changing congenital birth defects. These birth defects include atrial septal defects, ventricular septal defects, Omphalocele, Craniosynostosis, and persistent pulmonary hypertension of the newborn (PPHN).

Carey Danis & Lowe Can Help

Carey Danis & Lowe is a national law firm with a strong reputation for expertly assisting families through the challenges of recovering losses after a child has been born with SSRI birth defects. Our defective drug lawyers understand the pain and suffering these children and their families endure, and are available to help.

Explore your legal options and compensation eligibility today during a free, no-obligation case evaluation.

Contact Carey Danis & Lowe by phone at 800.721.2519, or submit a confidential personal injury claim form.

We look forward to offering you and your family any assistance that we can.

Paxil Birth Defects Mass Tort Update, Approaching End

By | Paxil, Pharmaceutical litigation, Uncategorized

SSRI Antidepressant Paxil Birth Defects LitigationThe Paxil birth defects mass tort currently being heard in a Philadelphia court is approaching conclusion. The mass tort once comprised approximately 1,000 lawsuits, and currently includes only two, according to an article recently published by Law.com.

A majority of the lawsuits in the Paxil mass tort were settled without a trial. Even so, a substantial number of these lawsuits were either transferred from the state court in Philadelphia to a federal court, or were sent back to their state of origin.

With legal proceedings wrapping up in Philadelphia, St. Louis is now considered the focal point for Paxil birth defects lawsuits, as a sizable number of cases are currently pending there.

Carey Danis & Lowe, a law firm headquartered in St. Louis, is hoping for a swift conclusion in these cases, as the lives of so many families have been negatively impacted.

Women across the country, along with their families, have filed lawsuits against the manufacturer of Paxil, GlaxoSmithKline, alleging that use of their SSRI antidepressant during pregnancy resulted in their children developing life-altering birth defects. Paxil birth defects range from heart defects, such as a hole in the heart, to persistent pulmonary hypertension of the newborn (PPHN) to Craniosynostosis. A more comprehensive list of birth defects can be reviewed here: Paxil birth defects list.

Carey Danis & Lowe Represents Victims of Paxil

Carey Danis & Lowe specializes in defective drug litigation, and currently represents women and their families in Paxil birth defects lawsuits. If you or a loved one used Paxil during pregnancy, and your child was born with a birth defect, we encourage you to begin reviewing your legal options and compensation eligibility with one of our defective drug lawyers today.

Our lawyers are available to listen to your Paxil story. Contact Carey Danis & Lowe by phone at 800.721.2519, or complete a confidential personal injury claim form.

Prozac Birth Defects Lawsuit News: Judge Rules to Include Plaintiff’s Accusations

By | Pharmaceutical litigation, Prozac, Uncategorized

prozac_lawsuit_prozac_birth_defects_litigation_settlementsIn the U.S. District Court for the Eastern District of California, where a Prozac birth defects lawsuit is being heard, Judge Lawrence K. Karlton ruled to maintain the plaintiff’s accusation of Eli Lilly’s Co.’s failure to warn. Furthermore, Judge Karlton found that the plaintiff’s additional claim that Prozac’s development betrayed Eli Lilly’s codes was sufficiently established, according to HarrisMartin. As such, evidence supporting these claims will be granted presentation in the court.

Carey Danis & Lowe Prozac lawyers believe that Judge Karlton’s decision to uphold the allegation of failure to warn is important. This means that the plaintiff has the opportunity to present a Prozac lawsuit in court that establishes Eli Lilly’s disregard for patient safety and neglectful business practices.

One of the most common Prozac birth defects is persistent pulmonary hypertension of the newborn (PPHN), a condition that affects normal lung function, resulting in a lack of properly oxygenated blood. In a study published by The New England Journal of Medicine in 2006, researchers found that the risk of PPHN increased six-fold in children whose mothers used a selective serotonin re-uptake inhibitor (SSRI) antidepressant, such as Prozac, during pregnancy.

Carey Danis & Lowe is a national law firm headquartered in St. Louis whose attorneys represent victims of SSRI birth defects. Our Prozac birth defects lawyers are currently offering free legal consultations of Prozac cases, and are available to discuss your legal options. We can also assist with filing a Prozac birth defects lawsuit.

If you have concerns about the impact Prozac has on children in the womb and after birth, receive thorough answers to your questions by discussing them with one of our on-staff medical experts. Share your story with Carey Danis & Lowe today by calling 800.721.2519, or by completing a confidential personal injury claim.

Evidence Strengthens Link Between SSRI Antidepressants and Congenital Birth Defects

By | Lexapro, Paxil, Pharmaceutical litigation, Uncategorized, Zoloft

zoloft_heart_birth_defect_ssri_pregnancyAccording to a European health care expert, pregnant women who take a selective serotonin reuptake inhibitor (SSRI) antidepressant early in pregnancy increase their child’s risk twofold of developing a heart defect. Professor Stephen Pilling of the National Institute for Health and Care Excellence (NICE) recently told the BBC that the birth defects risks associated with SSRI antidepressants are on par, if not more severe, than those linked to alcohol or tobacco use by pregnant women.

Pilling went on to state that the warnings communicated to pregnant women taking an SSRI antidepressant will soon be updated to include information about the strong link between SSRIs and birth defects. In Pilling’s opinion, the risk of heart defects outweighs, in some cases, the risk to the pregnant mother in terms of whether to discontinue use of an SSRI antidepressant in early pregnancy.

Carey Danis & Lowe is a national law firm with attorneys that represent women and their families in SSRI birth defects lawsuits. Our SSRI birth defects lawyers view Pilling’s statements as positive news for women and their families who claim that their child’s birth defects are the result of exposure to an SSRI antidepressant.

If you or someone you love took an SSRI antidepressant during pregnancy, and your baby developed a heart defect, such as a hole in the heart, or other congenital birth defects, contact an SSRI birth defects lawyer at Carey Danis & Lowe.

Call 800.721.2519, and share your case with us.

Carey Danis & Lowe Announces Launch of New Website Design

By | Class Action, Consumer protection, Defective Medical Device litigation, Pharmaceutical litigation, Uncategorized

Published August 14, 2013 by PR Web

As the St. Louis based law firm specializes in pharmaceutical and medical device litigation, the new design of the Carey Danis & Lowe website prioritizes these practice areas. Additionally, the new website design creates more accessibility to vital information for clients and those seeking legal counsel.

St. Louis, Missouri (PRWEB) August 14, 2013

Carey Danis & Lowe New Attorney WebsiteThe St. Louis based law firm, Carey Danis & Lowe, recently launched a new website design with a fresh look and prioritized focus. The website redesign features a cleaner and brighter color palette and overall larger graphical and textual elements, making the website’s content more accessible.

According to the Carey Danis & Lowe team, the updated design is intended to make the process of seeking out more information easier for individuals who are looking for answers to their questions about SSRI birth defects, transvaginal mesh, or any other Carey Danis & Lowe practice area. Evidence of this is in the updates to the navigation bar and the claim form.

The new layout of the navigation bar places an emphasis on the law firm’s work in pharmaceutical and medical device litigation. The reason for this emphasis on defective drugs and medical devices comes from both the success of the attorneys at Carey Danis & Lowe in winning class action lawsuits in these areas as well as the amount of inquiries received for legal counsel about certain drugs or devices.

In order to reach out to as many individuals as possible who are in need of legal counsel, Carey Danis & Lowe placed their online contact form in a prominent position in the right sidebar in the new layout of their website. This prominent placement is meant to encourage individuals who are seeking legal services to contact either an attorney or a medical expert at Carey Danis & Lowe. With the updated website layout, Carey Danis & Lowe seeks to make contacting one of their legal or health care experts an easy and open process.

Carey Danis & Lowe is proud to have launched its new website, and looks forward to hearing feedback in the future about its refreshed design, continuously updated content in the Firm News section, and the convenience of contacting either an attorney or a medical expert.

For more information about legal services provided by the attorneys at Carey Danis & Lowe, call 800-721-2519.

——

ABOUT CAREY DANIS & LOWE

Carey Danis & Lowe is a plaintiff’s litigation firm based in St. Louis, Missouri with law offices across the United States in Illinois, Missouri, and Florida. Carey Danis & Lowe specializes in defective drug and pharmaceutical litigation and class action lawsuits. The Carey Danis & Lowe team is comprised of experienced attorneys working alongside knowledgeable professional staff that includes medical doctors, nurses, and information technology specialists. Contact Carey Danis & Lowe at 800-721-2519 for more information.

Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect Cases

By | Pharmaceutical litigation, Uncategorized, Zoloft

Zoloft MDL Updates: Zoloft MDL No. 2342 Progresses with Order to Submit Initial Discovery Zoloft Birth Defect CasesThe Zoloft Multi-District Litigation No. 2342 being heard in the U.S. District Court for the Eastern District of Pennsylvania has made progress as regards setting the date for the first trial. According to Pre-trial Court Order 15, the first trial is currently scheduled for September 12, 2014. This is a tentative date that is dependent upon completion of all pertinent discovery by both sides.

This same court document from the Zoloft MDL details that by January 11, 2013, both the Defense and the Plaintiff’s counsel must deliver selections pertaining to Initial Discovery Group Cases, which will help in determining which cases enter the Trial Pool Cases.

The court has ordered that selections of cases that are representative enough for Trial Pool Cases should be supplied to the court by March 15, 2013.

According to a December 2012 article published by The Madison Record, there are currently 250 Zoloft cases that have been consolidated into the Pennsylvania MDL. What is more, there remain a number of Zoloft lawsuits pending in state courts that have not yet been consolidated into the MDL. State courts hearing these Zoloft lawsuits include Illinois, Missouri, New York, Pennsylvania, and West Virginia.

Plaintiffs in the Zoloft MDL claim that the use of Zoloft during pregnancy resulted in the development of birth defects in newborn children. These Zoloft birth defects include, but are not limited to, the following:

  • Congenital heart defects
  • Atrial septal defects
  • Ventricular septal defects
  • Omphalocele
  • Craniosynostosis
  • Persistent Pulmonary Hypertension of the Newborn (PPHN)

Zoloft is an anti-depressant drug manufactured by Pfizer. Zoloft is categorized as a selective serotonin re-uptake inhibitor, or SSRI. These types of antidepressants have a strong link to the development of birth defects in children exposed to an SSRI drug while in the womb.

If your newborn child was exposed to the SSRI medication Zoloft while in the womb, and as a result, developed life-altering and health compromising birth defects, you and your child may be entitled to receive recompense for your physical suffering, emotional suffering, and medical expenses.

For more information about filing a Zoloft birth defect lawsuit, contact an experienced trial lawyer at Carey Danis & Lowe. Our pharmaceutical product liability lawyers will provide you with a free legal consultation about your Zoloft case. Call a Zoloft lawyer at Carey Danis & Lowe today at 800.721.2519.

Carey Danis & Lowe Tackle Paxil Birth Defect Claims

By | Paxil, Pharmaceutical litigation, Uncategorized

Published October 12, 2012 by LawsuitInformation.org

Carey Danis & Lowe Tackle Paxil Birth Defect ClaimsPlaintiff’s litigation firm Carey Danis & Lowe is currently accepting new cases regarding Paxil and its link to birth defects when taken by expectant mothers during pregnancy. Paxil lawsuits have cropped up throughout the United States in response to the life altering, and in some cases life threatening, Paxil caused birth defects in newborn babies.

Paxil is an antidepressant drug classified as a selective serotonin re-uptake inhibitor, or an SSRI. It is known generically as Paroxetine. Paxil was developed by GlaxoSmithKline, a British pharmaceutical company.

In July 2012, GlaxoSmithKline pleaded guilty to federal charges claiming, among many other wrongdoings on part of the pharmaceutical giant, that they failed to properly inform the U.S. Food and Drug Administration (FDA), physicians, and patients about data collected in Paxil’s clinical trials. In fact, it has surfaced that GlaxoSmithKline withheld important information about the drug Paxil, information which could have saved lives. GlaxoSmithKline agreed to pay $3 billion in fines to the federal government – the largest health care fraud settlement in U.S. history.

Recently, GlaxoSmithKline made an announcement about its new effort towards transparency. In the announcement made in early October, the British drug maker stated that it would make public the data collected during clinical trials, which was not the case in regards to Paxil’s clinical trials. However, for many patients who used Paxil, such an effort on the part of GlaxoSmithKline is too late.

Pharmaceutical product liability and personal injury attorneys at Carey Danis & Lowe recognize that there are still families out there whose children have suffered from Paxil related birth defects. The lawyers at Carey Danis & Lowe are currently investigating new claims against drug’s maker, GlaxoSmithKline. If your family has been a victim of Paxil birth defects, contact the experienced attorneys at Carey Danis & Lowe for more information about filing a Paxil lawsuit. Call 800-721-2519 for a free legal consultation.